Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Guzzo

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Journal of the American Academy of Dermatology|December 1, 1991
A review of two controlled multicenter trials comparing 0.05% halobetasol propionate ointment to its vehicle in the treatment of chronic eczematous dermatosesC A Guzzo, J S Weiss, H S Mogavero, et al.
Clinical Therapeutics|May 20, 1998
Mometasone furoate 0.1%-salicylic acid 5% ointment versus mometasone furoate 0.1% ointment in the treatment of moderate-to-severe psoriasis: a multicenter studyJ Koo, C A Cuffie, D J Tanner, et al.
The Journal of Experimental Medicine|September 7, 2000
Blockade of T lymphocyte costimulation with cytotoxic T lymphocyte-associated antigen 4-immunoglobulin (CTLA4Ig) reverses the cellular pathology of psoriatic plaques, including the activation of keratinocytes, dendritic cells, and endothelial cellsJ R Abrams, S L Kelley, E Hayes, et al.
The Journal of Clinical Investigation|May 4, 1999
CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgarisJ R Abrams, M G Lebwohl, C A Guzzo, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Journal of the American Academy of Dermatology|December 1, 1991
A review of two controlled multicenter trials comparing 0.05% halobetasol propionate ointment to its vehicle in the treatment of chronic eczematous dermatosesC A Guzzo, J S Weiss, H S Mogavero, et al.
Clinical Therapeutics|May 20, 1998
Mometasone furoate 0.1%-salicylic acid 5% ointment versus mometasone furoate 0.1% ointment in the treatment of moderate-to-severe psoriasis: a multicenter studyJ Koo, C A Cuffie, D J Tanner, et al.
The Journal of Experimental Medicine|September 7, 2000
Blockade of T lymphocyte costimulation with cytotoxic T lymphocyte-associated antigen 4-immunoglobulin (CTLA4Ig) reverses the cellular pathology of psoriatic plaques, including the activation of keratinocytes, dendritic cells, and endothelial cellsJ R Abrams, S L Kelley, E Hayes, et al.
The Journal of Clinical Investigation|May 4, 1999
CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgarisJ R Abrams, M G Lebwohl, C A Guzzo, et al.
Pageof 4